
The oxadiazoles are a class of antibacterials discovered by in silico docking and scoring of compounds against the X-ray structure of a penicillin-binding protein. These antibacterials exhibit activity against Gram-positive bacteria, including against methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-resistant Enterococcus (VRE). They show in vivo efficacy in murine models of peritonitis/sepsis and neutropenic thigh MRSA infection. They are bactericidal and orally bioavailable. The oxadiazoles show promise in treatment of MRSA infection.
Methicillin-Resistant Staphylococcus aureus, Mice, Inbred ICR, Oxadiazoles, Quantitative Structure-Activity Relationship, Microbial Sensitivity Tests, Peritonitis, Staphylococcal Infections, beta-Lactams, Anti-Bacterial Agents, Vancomycin-Resistant Enterococci, Mice, Animals, Female
Methicillin-Resistant Staphylococcus aureus, Mice, Inbred ICR, Oxadiazoles, Quantitative Structure-Activity Relationship, Microbial Sensitivity Tests, Peritonitis, Staphylococcal Infections, beta-Lactams, Anti-Bacterial Agents, Vancomycin-Resistant Enterococci, Mice, Animals, Female
| citations This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 51 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Top 10% | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Top 10% | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Top 10% |
